Publications by authors named "Shane M Devlin"

Claim this Profile
W
When Perfect Is the Enemy of Good: Results of a RAND Appropriateness Panel on Treat to Target in Asymptomatic Inflammatory Bowel Disease.
Hannah K Systrom, Victoria Rai, Siddharth Singh, Leonard Baidoo, Adam S Cheifetz, Shane M Devlin

Am J Gastroenterol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Innovative Care for Inflammatory Bowel Disease Patients during the COVID-19 Pandemic: Use of Bedside Intestinal Ultrasound to Optimize Management.
Cathy Lu, Christopher Ma, Richard J M Ingram, Melissa Chan, Hengameh Kheirkhahrahimabadi, Shane M Devlin

J Can Assoc Gastroenterol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complementary and alternative medications in the management of inflammatory bowel disease.
Sherman Picardo, Mansour Altuwaijri, Shane M Devlin, Cynthia H Seow

Therap Adv Gastroenterol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Appropriate Therapeutic Drug Monitoring of Biologic Agents for Patients With Inflammatory Bowel Diseases.
Konstantinos Papamichael, Adam S Cheifetz, Gil Y Melmed, Peter M Irving, Niels Vande Casteele, Shane M Devlin

Clin Gastroenterol Hepatol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Canadian Association of Gastroenterology Position Statement: Use of Cannabis in Gastroenterological and Hepatic Disorders.
Christopher N Andrews, Shane M Devlin, Bernard Le Foll, Benedikt Fischer, Frances Tse

J Can Assoc Gastroenterol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Appropriateness of Combination Therapy for Patients With Inflammatory Bowel Diseases: One Size Still Does Not Fit All.
Gil Y Melmed, Gilaad G Kaplan, Miles P Sparrow, Fernando S Velayos, Leonard Baidoo, Shane M Devlin

Clin Gastroenterol Hepatol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world clinical, endoscopic and radiographic efficacy of vedolizumab for the treatment of inflammatory bowel disease.
Paulo G Kotze, Christopher Ma, Abdulelah Almutairdi, Ahmed Al-Darmaki, Shane M Devlin

Aliment Pharmacol Ther· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preoperative Ustekinumab Treatment Is Not Associated With Increased Postoperative Complications in Crohn's Disease: A Canadian Multi-Centre Observational Cohort Study.
Hang Hock Shim, Christopher Ma, Paulo G Kotze, Cynthia H Seow, Heba Al-Farhan, Shane M Devlin

J Can Assoc Gastroenterol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term Maintenance of Clinical, Endoscopic, and Radiographic Response to Ustekinumab in Moderate-to-Severe Crohn's Disease: Real-world Experience from a Multicenter Cohort Study.
Christopher Ma, Richard N Fedorak, Gilaad G Kaplan, Levinus A Dieleman, Shane M Devlin

Inflamm Bowel Dis· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Appropriateness of Testing for Anti-Tumor Necrosis Factor Agent and Antibody Concentrations, and Interpretation of Results.
Gil Y Melmed, Peter M Irving, Jennifer Jones, Gilaad G Kaplan, Patricia L Kozuch, Shane M Devlin

Clin Gastroenterol Hepatol· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recommendations for Quality Colonoscopy Reporting for Patients with Inflammatory Bowel Disease: Results from a RAND Appropriateness Panel.
Shane M Devlin, Gil Y Melmed, Peter M Irving, David T Rubin, Asher Kornbluth

Inflamm Bowel Dis· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defining quality indicators for best-practice management of inflammatory bowel disease in Canada.
Geoffrey C Nguyen, Shane M Devlin, Waqqas Afif, Brian Bressler, Steven E Gruchy

Can J Gastroenterol Hepatol· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A survey of perceptions and practices of complementary alternative medicine among Canadian gastroenterologists.
Zane Gallinger, Brian Bressler, Shane M Devlin, Sophie Plamondon, Geoffrey C Nguyen

Can J Gastroenterol Hepatol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overview of subsequent entry biologics for the management of inflammatory bowel disease and Canadian Association of Gastroenterology position statement on subsequent entry biologics.
Shane M Devlin, Brian Bressler, Charles N Bernstein, Richard N Fedorak, Alain Bitton

Can J Gastroenterol· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Colometer: a real-time quality feedback system for screening colonoscopy.
Dobromir Filip, Xuexin Gao, Leticia Angulo-Rodríguez, Martin P Mintchev, Shane M Devlin

World J Gastroenterol· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Do thiopurines prevent advanced colorectal neoplasia in patients with inflammatory bowel disease or is this an unanswerable question?
Shane M Devlin

Inflamm Bowel Dis· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-specific approach to combination versus monotherapy with the use of antitumor necrosis factor α agents for inflammatory bowel disease.
Shane M Devlin, Adam S Cheifetz, Corey A Siegel,

Gastroenterol Clin North Am· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of variables associated with smoking cessation in Crohn's disease.
Yvette Leung, Gil G Kaplan, Kevin P Rioux, James Hubbard, Sarah Kamhawi, Shane M Devlin

Dig Dis Sci· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The appropriateness of concomitant immunomodulators with anti-tumor necrosis factor agents for Crohn's disease: one size does not fit all.
Gil Y Melmed, Brennan M Spiegel, Brian Bressler, Adam S Cheifetz, Shane M Devlin

Clin Gastroenterol Hepatol· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolving inflammatory bowel disease treatment paradigms: top-down versus step-up.
Shane M Devlin, Remo Panaccione

Med Clin North Am· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Managing the risks of IBD therapy.
Cynthia H Seow, Shanika de Silva, Gilaad G Kaplan, Shane M Devlin, Subrata Ghosh

Curr Gastroenterol Rep· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolving inflammatory bowel disease treatment paradigms: top-down versus step-up.
Shane M Devlin, Remo Panaccione

Gastroenterol Clin North Am· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammatory bowel disease patients who leave hospital against medical advice: predictors and temporal trends.
Gilaad G Kaplan, Remo Panaccione, James N Hubbard, Geoffrey C Nguyen, Abdel Aziz M Shaheen, Shane M Devlin

Inflamm Bowel Dis· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current Controversies in Crohn's Disease: A Roundtable Discussion of the BRIDGe Group.
Miles P Sparrow, Peter M Irving, Leonard Baidoo, Brian Bressler, Adam S Cheifetz, Shane M Devlin

Gastroenterol Hepatol (N Y)· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adalimumab for the treatment of Crohn's disease.
Shane M Devlin, Remo Panaccione

Expert Opin Biol Ther· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis